Providing Support to Develop Promising Ideas

The Innovation Grants Program helps researchers and students at our affiliated organizations -- Kessler Foundation, New Jersey Institute of Technology, Princeton University, Rowan University, Rutgers University and Stevens Institute of Technology -- continue to advance their research by providing grants of up to $50,000 to support further development of their work.  Grants must be used to fund only direct program costs.  Grants cannot be used to fund overhead, tuition or any other indirect costs.


We created the Innovation Grants Program to help address an important need of researchers in the middle stage of our funding continuum  – in between very early research ideas and those ready to form companies. 


Many of the researchers who receive Innovation Grants have great ideas but lack access to funding and other resources to further their research. Most do not have an understanding of the business processes required to achieve their goal – proof of concept and commercialization of their work to make their device or treatment available to those who need it. 

Our commitment to the researchers and students goes beyond the grant funding  we provide.  Our team provides mentoring and direction to researchers.


Recently supported projects hold the promise of creating tremendous benefits for society. Researchers are investigating ways to detect the early onset of dementia, investigating novel treatments for alcohol use disorder, combating diabetes, treating intraocular diseases, developing insect repellents to improve global health, and researching approaches to combat cancers and allergic inflammation. 

To obtain more information, please click here.

Help us support cutting-edge research!

Foundation for Health Advancement accepts contributions from corporations, foundations and individuals to support this program.  100% of funds raised for the Innovation Grant Program will be used for grants to support research.

To support this important work, please click here. 


Active Grants Include:

Simplified Transaction Device, Dorian Wilson, MD, Rutgers University
Therapeutic for Parkinson's Disease, M. Maral Mouradian, MD, Rutgers University
"Smart" Polyelectrolyte Nanomedicine for Cystic Fibrosis Pneumonia, Graplon Therapeutics, Rutgers University
Targeting Mast Cell Development to Combat Allergic Reaction, NemaGen Discoveries, Inc., Rutgers University
Development of a rapid, low cost method to identify infection origin, Adam Gormley, Rutgers University 
Dihydromyricetin Analogs for Treatment of Alcohol Use Disorder, James Simon, PhD, Eileen Carry, PhD, David Augeri, PhD, Rutgers University



Successfully Advancing Medical Research

Since the inception of the Innovation Grants Program, there have been over 30 projects that have been funded.  Two of the innovation grants led to the formation of companies. Twelve of these projects are active in various stages.